Scientists find strong evidence for testing newly developed drug in liver cancer

byVirginia Commonwealth UniversityDevanand Sarkar, M.B.B.S., Ph.D. Credit: VCU Massey Cancer CenterResearchers at VCU Massey Cancer Center have published new study findings that establish ration

Updated on: December 27,2023

Scientists find strong evidence for testing newly developed drug in liver cancer

byVirginia Commonwealth UniversityDevanand Sarkar, M.B.B.S., Ph.D. Credit: VCU Massey Cancer CenterResearchers at VCU Massey Cancer Center have published new study findings that establish ration

Updated on:December 27,2023

The architectural role of p53: Early 3D chromatin remodeling to trigger cellular stress response

byJosep Carreras Leukaemia Research InstituteTAD dynamics along p53 activation. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46666-1The simplest explanation of cancer

Updated on: April 28,2024

The architectural role of p53: Early 3D chromatin remodeling to trigger cellular stress response

byJosep Carreras Leukaemia Research InstituteTAD dynamics along p53 activation. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46666-1The simplest explanation of cancer

Updated on:April 28,2024

Study investigates the unresolved palliative care needs of elderly, homebound noncancer patients

by University of TsukubaCredit: Kampus Production from PexelsIn Japan, approximately 70% of deaths occur among noncancer patients who often experience more frequent and varied distressing symptom

Updated on: March 15,2024

Study investigates the unresolved palliative care needs of elderly, homebound noncancer patients

by University of TsukubaCredit: Kampus Production from PexelsIn Japan, approximately 70% of deaths occur among noncancer patients who often experience more frequent and varied distressing symptom

Updated on:March 15,2024

Researchers look at post menopause as key factor in endometrial cancer

byMayo ClinicCredit: CC0 Public DomainEndometrial cancer is the most common gynecological malignancy in the U.S. and the fourth most common cancer among women. In addition, endometrial cancer in

Updated on: December 23,2023

Researchers look at post menopause as key factor in endometrial cancer

byMayo ClinicCredit: CC0 Public DomainEndometrial cancer is the most common gynecological malignancy in the U.S. and the fourth most common cancer among women. In addition, endometrial cancer in

Updated on:December 23,2023

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Updated on: October 30,2023

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Updated on:October 30,2023

AI in Oncology: Balancing Innovation with Ethical Oversight

Updated on: July 21,2025

AI in Oncology: Balancing Innovation with Ethical Oversight

Updated on:July 21,2025

Study finds early switch to oral antibiotic therapy for S. aureus bloodstream infections is safe, effective

by University of CologneCredit: Unsplash/CC0 Public DomainA new study shows efficacy and safety of oral antibiotic therapy, in the form of pills, for Staphylococcus aureus bloodstream infections.

Updated on: May 07,2024

Study finds early switch to oral antibiotic therapy for S. aureus bloodstream infections is safe, effective

by University of CologneCredit: Unsplash/CC0 Public DomainA new study shows efficacy and safety of oral antibiotic therapy, in the form of pills, for Staphylococcus aureus bloodstream infections.

Updated on:May 07,2024

Gut microbiome can play key role in response to CAR-T cell cancer immunotherapy

byGerman Cancer Research CenterCredit: Unsplash/CC0 Public DomainScientists from German Cancer Research Center (DKFZ), together with colleagues from Germany, Israel, and the U.S., have found tha

Updated on: December 19,2023

Gut microbiome can play key role in response to CAR-T cell cancer immunotherapy

byGerman Cancer Research CenterCredit: Unsplash/CC0 Public DomainScientists from German Cancer Research Center (DKFZ), together with colleagues from Germany, Israel, and the U.S., have found tha

Updated on:December 19,2023

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d

Updated on: December 20,2023

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d

Updated on:December 20,2023

More breast cancer patients can choose smaller surgery

by Carla K. JohnsonA technician displays images of a mammogram scan on a computer screen at a hospital in Odessa, Texas, on Wednesday, Oct. 20, 2021. A study discussed Friday, Dec. 9, 2022, at the San

Updated on: December 22,2023

More breast cancer patients can choose smaller surgery

by Carla K. JohnsonA technician displays images of a mammogram scan on a computer screen at a hospital in Odessa, Texas, on Wednesday, Oct. 20, 2021. A study discussed Friday, Dec. 9, 2022, at the San

Updated on:December 22,2023

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on: December 18,2023

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on:December 18,2023

Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

byUniversity of Texas M. D. Anderson Cancer Center3D rendering of a B cell. Credit: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2).

Updated on: December 19,2023

Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

byUniversity of Texas M. D. Anderson Cancer Center3D rendering of a B cell. Credit: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2).

Updated on:December 19,2023